There is a major lack of randomized controlled clinical trials evaluating the efficacy of prismatic treatments for hemianopia. Evidence for their effectiveness is mostly based on anecdotal case reports and open-label evaluations without a control condition.
A lthough prismatic corrections have been used in the rehabilitation of homonymous hemianopia (HH) for at least the last 80 years, 1 evidence for their effectiveness is almost exclusively based on anecdotal case reports [2] [3] [4] and open-label evaluations without a control condition. [5] [6] [7] [8] [9] [10] Recent reviews of a range of interventions for patients with homonymous visual field loss have underscored the need for randomized controlled clinical trials in this area. [11] [12] [13] [14] To the best of our knowledge, there have only been 3 controlled studies [15] [16] [17] of prismatic devices for HH, and each had substantial limitations (eTable 1 in the eAppendix in the Supplement).
In 2000, Peli 7 described a new approach-peripheral prism glasses-to fitting prisms for HH. High-power prism segments fitted unilaterally on the upper and lower peripheral parts of the spectacle lens provide up to 30°of lateral visual field expansion with 57-prism diopter (Δ) prisms ( Figure 1 and Figure 2 ). As the prism images fall on peripheral retina, central diplopia, common with other designs, is avoided. An evidence base for the efficacy of peripheral prism glasses has gradually been built through a series of open-label studies, including a laboratory-based study, 8 a multicenter clinical trial, 9 and most recently an independent (not initiated by Peli) singlecenter clinical study. 10 Clinical success rates were good in each study, with 47% 9 to 83% 10 of participants continuing to use the prism glasses in the long term, reporting that they were helpful for obstacle avoidance when walking. While these findings are promising, none of the studies included a control group or a control treatment. Herein, we report a controlled multicenter trial of the peripheral prism glasses using a crossover design in which each patient wore a pair of real (57Δ) and a pair of sham prism glasses (<5Δ). Our primary hypothesis was that participants would be more likely to want to continue to use the real than the sham prism glasses, because they would find them more helpful for detecting hazards when walking. Our secondary study goal was to establish preliminary comparative data on 2 peripheral prism configurations: the original "horizontal" design 7 and a more recent "oblique" design 18 ( Figure 1A and B). We hypothesized that there would be no difference in continuation rates for the 2 designs because both provide visual field expansion in areas likely to be helpful when walking ( Figure 2B and C). However, the oblique design may be advantageous for driving. A, Without peripheral prisms. B, With 57-prism diopter (Δ) horizontal peripheral prisms. C, With 57Δ oblique peripheral prisms, as fitted for the study with a 12-mm interprism separation. Both designs provide close to 30°of lateral expansion into the blind hemifield (slightly more for the horizontal than the oblique design). The expansion is in more central areas of the field with the oblique design. Small black squares are the individual points mapped during the perimetry.
Methods
Schepens Eye Research Institute was the coordinating and data management center for the study. Data were collected at 13 study sites, including the Peli laboratory at Schepens, 11 vision rehabilitation clinics in the United States, and 1 in the United Kingdom. The clinics included university, hospital, and private practice clinics. Each site recruited a median of 7 participants (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Before screening, the nature of the study was explained and written informed consent was obtained from all participants. The study adhered to the tenets of the Declaration of Helsinki and was approved by the institutional review board at Schepens and by local institutional review boards for study sites with an institutional review board. Data were collected in the period from October 2007 to January 2010. Study visits are summarized in Table 1 . Procedures are detailed in the eAppendix in the Supplement.
Participants
Participants were recruited by practitioners at each study site. The primary inclusion criteria were complete HH 8 ), and no history of having worn peripheral prism glasses. In addition, participants had corrected monocular visual acuity of at least 20/50 in each eye, refractive error within the −5 diopter (D) to +5 D range, no strabismus, no significant cognitive decline (Short Portable Mental Status Questionnaire 22 ), and no balance problems or other deficits that could impair ability to walk or use the prism glasses. Visual field mapping extended to at least 50°from fixation in all directions and was performed using Goldmann perimetry (V4e target), a Humphrey Field Analyzer 120-point full-field screening test, or similar tests, depending on the equipment available at each clinic. To ensure that study inclusion criteria were uniformly applied, screening data were sent to the principal investigator (A.R.B.), who determined eligibility.
Study Design
The study was a double-masked, multicenter crossover trial of real and sham peripheral prism glasses with a counterbalanced AB/BA design (AB = real first; BA = sham first). Each crossover period was 4 weeks. A washout period was not included because no carryover effects were anticipated. To address our secondary goal of providing preliminary comparative data on the oblique and horizontal designs, participants were allocated to receive either real oblique and sham horizontal prism glasses or real horizontal and sham oblique.
At the end of the crossover, a clinical decision whether to continue wearing the real prism glasses was made. For participants who continued, a follow-up telephone interview was conducted approximately 6 months after their final in-office visit (Table 1 and Procedures in the eAppendix in the Supplement).
Treatment Allocation
The clinical coordinator at Schepens assigned participants to 1 of 4 possible treatment allocations (real oblique AB/BA and real horizontal AB/BA) using minimization 23 (Minim software; S. Evans, S. Day, and P. Royston, http://www-users.york .ac.uk/~mb55/guide/minim.html). The first participant was assigned randomly, with each subsequent participant assigned in such a way as to minimize imbalances among the 4 treatment allocations. We could realistically balance for only 2 factors. Study site was the primary factor (because continuation rates varied significantly across sites in our first multicenter study 9 ) and side of HH (right or left) was the second factor (because the side of the lesion could potentially affect performance with the prism glasses). We did not balance for age because it was not a significant factor affecting continuation rates in our previous study. 9 Letter codes, randomly assigned to each of the treatment allocations by a researcher external to the study, were used by the Minim software and in all data records and spreadsheets. There were 2 copies of the code breaker: the first was kept in a sealed envelope in a location known only to the external researcher and the second was sent to Chadwick Optical, Inc so that the correct combinations of prism glasses could be manufactured for each participant. The code was not broken at Schepens until data analyses were completed.
Real and Sham Prism Glasses
The real and sham prism glasses (manufactured by Chadwick Optical, Inc) both comprised an upper and lower rigid Fresnel prism segment with a 12-mm separation 9 embedded in a regular distance-vision spectacle lens in front of the eye on the side of the HH. They differed only in the design (horizontal vs oblique) and the prism power: 57Δ for the real prisms ( Figure 1A and B) and 5Δ for the sham prisms ( Figure 1C ). An extra optical element included with the sham prisms provided visual acuity reduction and chromatic dispersion similar to those experienced with the 57Δ prisms and also reduced the prism power by about 2Δ from the original 5Δ. Hence, the sham prisms provided no useful field expansion (<2°). For the horizontal design, the prisms were base out. For the oblique design, the upper prism was placed base out and down and the lower prism was placed base out and up, with the base-apex line at an angle of tilt of 25°to the horizontal ( Figure 1C ).
Masking
Double-masking was used, with participants and data collectors being masked as far as possible. In addition, the principal investigator (A.R.B.) who conducted data analyses was masked. However, it was impossible to mask all study personnel; there was an unmasked practitioner at each site who fitted the prism glasses and dealt with clinical aspects of patient care. Participants were informed that they were evaluating 2 different designs of prism glasses; they were not told that 1 pair was a sham. If they asked about the difference, the practitioner commented on the physical difference of the vertical vs tilted grooves on the Fresnel prism inserts for the horizontal and oblique designs, respectively. To prevent investigator bias, the data collector at each site was unaware of the treatment allocation and the study glasses were retained by the (unmasked) practitioner while the questionnaires were administered. Patients never had possession of both pairs together.
Primary Outcome Measure
At the end of each crossover period, participants were asked a yes/no question: "If the study were to end today, would you want to continue with these prism glasses (ie, the prism glasses worn in that period)?" Our primary outcome was the overall difference, across the 2 periods of the crossover, between the proportion of participants saying yes to real glasses and the proportion saying yes to sham glasses.
Secondary Outcome Measure
Perceived difficulties with mobility were quantified using a 5-point rating scale (no difficulty to extreme difficulty) for 7 situations (items) relevant to HH, including at home, in stores, outdoors, in unfamiliar areas, in familiar areas, in crowded areas, and noticing objects off to the side when walking. 8, 24 The questionnaire was administered at baseline (without prisms) and after each period of the crossover. Interval scale measures 25 of perceived difficulty with overall mobility for each participant were estimated using Rasch analysis of the responses to all 7 items (WINSTEPS software, version 3.70.0. 2 26 ). Rasch measures were expressed as logits (log odds ratios). Mobility improvement scores for real and sham prisms were defined as the difference in perceived difficulty relative to baseline (in logits). Psychometric properties of the questionnaire were good (eTable 2 in the eAppendix in the Supplement).
Comparison Questionnaire
At the end of the crossover, participants completed a comparison questionnaire about the 2 pairs of glasses. They did not have access to the glasses while answering the questions and the questionnaire was administered before they were told that one pair was a sham (debriefing came later [Procedures in the eAppendix in the Supplement]). Questions included: "Which pair would you select (first pair, second pair, or neither)?" "Which pair was better for obstacle avoidance when walking?" "Which pair gave more comfortable vision?" These last 2 questions were scored on a 5-point scale from first pair much better to second pair much better.
Statistical Analyses
The sample size calculation for the primary outcome measure was based on a McNemar test for a 2 × 2 contingency table of the yes/no responses to real and sham prism glasses for data combined across both periods of the crossover (StudySize software, version 2.0.4; CreoStat HB). In our previous open-label multicenter study, 9 74% of participants continued with (real) peripheral prism glasses after an initial 4-week trial. We therefore estimated that 70% of participants would say yes to the real prism glasses in this study and that half that number (35%) would say yes to the sham prism glasses. For a 2-tailed test, the minimum sample size to detect a 35% difference in yes responses to real and sham prism glasses was 57 participants, assuming 30% overlap (ie, 30% said yes to both pairs of glasses), power of 90%, and significance (α) level of 1%. Assuming 9 an attrition rate of 20%, we planned to enroll at least 68 participants. As planned, the primary outcome measure was analyzed using a McNemar test for data combined across both periods of the crossover. In addition, the proportions of participants saying yes to real and yes to sham prism glasses at the end of each period were compared using a 2-proportion z test. As a secondary measure, the proportion expressing a preference for the real prism glasses at the end of the crossover was analyzed using a binomial confidence interval test.
Mobility improvement scores, the secondary outcome measure, were normally distributed. Our primary analysis was a within-subjects comparison of the crossover differences in mobility scores between real and sham prism glasses, analyzed using a paired t test. In addition, differences in mobility scores between patients wearing real and sham prisms were analyzed for each period of the crossover using an independentsamples t test. In our prior open-label multicenter trial, 9 participants who continued wearing peripheral prism glasses gave significantly higher mobility helpfulness ratings for the glasses than participants who discontinued wear. We therefore conducted subgroup analyses of mobility improvement scores based on final status (continuing wear or discontinued wear) at the 6-month interview. When questionnaires were administered, patients did not know that one pair of glasses was real and one pair was sham; however, for clarity in reporting of results, participant responses have been converted to real or sham glasses rather than first or second pair. All analyses were 2-sided. An α value ≤.01 was considered to indicate statistical significance for the primary analysis and ≤.05 for the secondary analyses.
Results
Seventy-three patients were enrolled, with 36 allocated to the real oblique group and 37 to the real horizontal group (Figure 3) . Twelve participants subsequently withdrew: 6 before the start of the crossover (3 because of transportation problems and 3 for no reason) and 6 more during the crossover (3 for health reasons, 1 for visual field recovery, 1 because of transportation problems, and 1 for no reason). Thus, 61 participants (66% male) with a median age of 58 years (range, 18-89 years) completed the crossover; 64% had left hemianopia. The median time since onset was 18 months (range, 3-396 months), with stroke the predominant cause (77%).
At the end of the crossover, 61% (19 of 31) continued prism wear in the oblique group and 60% (18 of 30) in the horizontal group (P = .92). At the long-term interview, 36% (11 of 31) and 47% (14 of 30) were still wearing the prism glasses in each group, respectively (P = .32). Thus, the overall continuation rate at 6 months was 41% (25 of 61).
In agreement with our prediction, there were no statistically significant differences between the oblique and horizontal groups for any of the outcome measures (eTable 3 in the eAppendix in the Supplement); therefore, data were pooled across the 2 groups for the main analyses reported later. Additional analyses are summarized in the eAppendix Results section in the Supplement, including a summary of reported difficulties with real and sham prism glasses; reasons for discontinuing wear; predictors of long-term wear; and debriefing data.
Primary Outcome Measure
In response to the question "would you want to continue with these prism glasses," the difference between the proportions of participants who said yes to real and yes to sham at the end of the first crossover period was not significant (P = .39) but was highly significant at the end of the second period (P = .001) ( Table 2 ). For data combined across the 2 periods of the crossover, the overall proportion of participants who said yes to the real prism glasses (64% [39 of 61]) was higher than the overall proportion saying yes to the sham prism glasses (36% [22 of 61]) ( Table 2 and Table 3 ). The 28% difference in these proportions, the primary outcome, was significant (95% CI, 12%-42%; McNemar test P = .001) ( Table 2 and Table 3 ).
Overall Mobility Improvement Score
Relative to baseline, there was a significant improvement in the overall mobility score for both real and sham prism glasses in both crossover periods (P < .01) ( Table 4) . However, the difference in the amount of improvement between participants wearing real and sham prism glasses was not significant in either period (P = .38 and .50, respectively) ( Table 4 ). In contrast, analysis of the within-subjects crossover differences revealed a trend toward greater improvement with the real than the sham prisms (P = .09) ( Table 4) . Subgroup analyses further revealed that participants who continued with prism glasses at the 6-month follow-up reported markedly more improvement for real than sham prisms at the end of the crossover (P = .002), whereas participants who discontinued wear reported little difference in the amount of perceived improvement for the 2 pairs of glasses (Table 4 and Figure 4 ).
Comparison Questionnaire
When asked which pair of glasses they would select at the end of the crossover, 61% (37 of 61) chose the real prism glasses; 26% (16 of 61), the sham glasses; and 13% (8 of 61), neither pair. The number of participants selecting real prism glasses approached significance when expressed as a proportion of the total number completing the crossover (61%; 95% CI, 48%-72%; P = .07) and was significant when expressed as a proportion of those who actually stated a preference (70% [37 of 53]; 95% CI, 56%-80%; P = .01). These results support the findings of the primary outcome measure.
Participants who selected real prism glasses rated them as much better for obstacle avoidance and vision comfort than sham prism glasses (median ratings) ( Figure 5) . By comparison, participants who selected sham prism glasses rated them as only slightly better than real prism glasses for obstacle avoidance and vision comfort (median ratings) ( Figure 5 ). Participants who selected neither pair of glasses gave a median rating of "no difference" for both these aspects. In a similar vein, the main reason given for selecting real prism glasses was that they were the pair of glasses that was more helpful when walking (92% [34 of 37]), whereas the main reasons for selecting sham prism glasses were that they were the pair with which vision was more comfortable (81% [13 of 16] ) and with which fewer difficulties had been encountered.
Discussion
Participants demonstrated a preference for real peripheral prism glasses over sham peripheral prism glasses. They were about 5 times more likely to say yes only to real prism glasses than yes only to sham prism glasses during the crossover (Table 2) (marginal odds ratio, 5.3), and 64% selected real prisms over sham prisms at the end of the crossover. Moreover, real prism glasses were rated as much more helpful than the sham for obstacle avoidance when walking. The proportion of participants who continued with real prism glasses was similar for the horizontal and oblique designs, suggesting that both designs were helpful for everyday pedestrian mobility. However, a preference for the oblique design might be expected for driving.
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The participants in this study were patients with complete HH without spatial neglect and without significant cognitive decline attending a range of hospital, university, and private practice clinics. As such, we believe the results to be highly generalizable to clinical rehabilitation of patients with similar characteristics. Furthermore, all procedures and data collection methods were based on current clinical practice.
Our results demonstrate the importance of including a control condition when evaluating a rehabilitation intervention. Specifically, 26% of participants selected the sham prism glasses at the end of the crossover. The reasons for their choice were related to vision comfort and lack of difficulties in using the glasses rather than improved functional performance. These are patients who in an open-label trial might artificially inflate success rates when only a short-term follow-up is included (eg, 1 month) because they would like to continue with the study intervention but for the wrong reasons and would likely discontinue use of the device before a longerterm follow-up (eg, 6 months). Indeed, the short-term success rate (continuation rate at the end of the crossover) was lower in this controlled trial than in our prior open-label trial 9 of the peripheral prism glasses (61% vs 74%), while long-term success rates were more similar (41% vs 47%). Furthermore, placebo effects were evident in the self-ratings of mobility difficulties; participants reported an improvement in overall mobility for both sham and real prism glasses. However, for participants who continued to wear prism glasses in the long term, the improvement was greater for the real than the sham glasses. Thus, for this subgroup, we were able to measure both treatment and placebo effects.
Although not a goal of this study, we evaluated the ability of a range of factors to predict long-term success (continuation rates) (eTable 6 in the eAppendix in the Supplement). The strongest predictors were participants' responses to the prism glasses at the end of the crossover. Unsurprisingly, those who said yes to real prism glasses, those who rated them as better than the sham for obstacle avoidance, and those who did not report any difficulties with them were more likely to continue wearing prism glasses in the long term. By comparison, age was only a weak predictor, and side and duration of hemianopia were not predictive (consistent with our prior openlabel trial 9 ). Difficulty interpreting the prism image was a major reason for discontinuing wear (eFigure and eTable 5 in the eAppendix in the Supplement). Limited training in how to use the prism glasses was provided, similar to that implemented in our prior study; however, it is possible that some participants might have benefited from more extensive training. We are currently evaluating the effects of intensive computerbased training for use of the peripheral prism glasses.
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In planning this study, our aim was to achieve a robust but practical design that would fit within a busy clinic schedule; however, some limitations need to be considered. Differing numbers of participants were recruited at each clinic and we were unable to ensure total masking of data collectors. Furthermore, our outcome measures were based on patient preference and self-report questionnaires. For practical reasons, evaluations of functional mobility performance, such as those used in laboratory-based studies of devices for visual field loss, [28] [29] [30] could not be used.
Our primary outcome measure was limited by period effects. Specifically, after the first crossover period, the differ- a ence in the proportion of participants saying yes to real and sham prism glasses was only 12%, compared with 44% after the second period. While responses at the end of the first period might have been affected by the knowledge that another pair of glasses was to be worn in the second period, responses at the end of the second period were clearly influenced by having already worn either real or sham glasses in the first period. Interestingly, period effects were less evident in the mobility improvement scores because the magnitude of the difference in perceived improvement between those wearing real and sham prism glasses was similar at the end of each period (Table 4) .
To evaluate the evidence base for a given treatment or intervention, systematic reviews synthesize data across trials. Combining results from crossover and parallel-arm trials is not easy; various methods have been proposed. [31] [32] [33] One straightforward approach is to use data from the first period only, as if from a parallel-arm trial; however, this means that valuable information from the second period may be lost and ignores the fact that the study was designed as a crossover. We suggest that the period effects present in our original primary outcome measure provide an example of a situation in which it would have been potentially misleading to include data from only the first crossover period.
In conclusion, this study addresses the lack of controlled trials identified in recent systematic reviews of interventions for homonymous visual field loss [11] [12] [13] [14] and strengthens the evidence base for the efficacy of peripheral prism glasses as a mobility aid for patients with HH. The next step should be a clinical trial with outcome measures evaluating functional performance on real-world or simulated mobility tasks. • Parallel arm study comparing treatment to no treatment group; • Treatment group received 15Δ bilateral yoked sector press-on Fresnel prisms base toward the affected side, fitted 2mm into the blind hemifield; • Follow up at 2 and 4 weeks; • Patients had either hemianopia or spatial neglect.
• At 4 weeks the treatment group performed better than the control group on neglect tests (line bisection and cancellation); • However, there were no significant between-group differences in the amount of improvement on the Barthel ADL-mobility score • Field "expansion" found in both the treatment and control groups
• Study performed in an in-patient stroke rehabilitation unit within the period when spontaneous visual field recovery and spontaneous neglect recovery could occur (enrolled on average within 5 weeks of the stroke); • As the prisms were fitted 2mm into the blind hemifield, they should have had no effect on the perimetry results (the eye is in primary gaze for perimetry), thus the improvements in visual field that were recorded were most likely due to spontaneous recovery.
• Data collectors were unmasked for the majority of outcome measures;
• At the follow ups, the treatment group were only tested with prisms and the no-treatment group were only tested without prisms; • The extent to which participants with hemianopia had complete or incomplete hemianopia at baseline is unclear Gottlieb (1992) 34
• Non-randomized crossover comparing Gottlieb 18.5Δ unilateral sector ophthalmic ground-in prism button to a control device, which appeared similar but included a "plano lens without prism power"; • Wore each device for 2 weeks;
• Patients had hemianopia either with or without spatial neglect.
• Ratings of device 'effectiveness' for mobility and localization were higher for the real than the sham prisms.
• All participants rejected the sham device.
• 19 still using the prism glasses after 18 months.
• Unclear whether all participants received both real and sham glasses;
• Lack of clarity in recruitment methods and study locations: "initial" phase (n = 8), "replication" phase (n = 16), and patients (n = 10) "added to the experimental population by the primary investigator" • Real prisms always received before sham prisms;
• Included people with hemianopia with and without visual neglect;
• Potential for bias as unclear who administered the questionnaire, and no details were reported about whether the person administering the response questionnaire was masked or whether the patients were masked; • No information provided on prism placement.
• Unclear who funded the study and whether participants had to pay for the prism glasses
Szylk (2005) 10
• Randomized crossover comparing Gottlieb style unilateral sector prisms in two designs (a) 18.5Δ ophthalmic ground-in prism (b) 20Δ presson Fresnel prism;.
• Three months of training with each type of lens; • Patients had hemianopia.
• No difference in performance with ophthalmic prism and press-on prism on a large test battery (lab tests, mobility tests, driving simulator and onroad driving); • 6 still using the prism glasses after 2 years.
• Performance on lab, mobility and driving tasks were pooled together in general categories; the effects on specific aspects of mobility or driving were not reported; • Study provided a comparison between two prismatic lenses where the only difference was in cosmetic appearance and image quality, but not in field expansion; thus a performance difference was not really expected.
• As the study did not include a no-treatment control group, or a no-training control group, there is no information about the effects of the prismatic correction alone or the effects of the training alone • No information about whether patients were screened to exclude neglect
Procedures
Each site was provided with detailed written protocols and data record sheets. After each participant contact, whether by phone or in-office visit, data sheets were sent to Schepens for review. Monitoring the data in this way ensured adherence to the protocols and that all participants were treated equally.
Screening tests, the baseline mobility questionnaire and measurements for prism glasses were conducted at the first visit. Presbyopic participants were given the option of a small bifocal segment below the lower prism segment, sufficient for short duration spot reading. Study frames (from a small selection) and lenses were provided free of charge to all participants.
For each participant who met the study criteria, Chadwick Optical, Inc. (White River Junction, Vermont) manufactured a pair of real and sham prism glasses. To ensure that participants received the glasses in the correct order, only the first pair was mailed to the practitioner for collection by the patient at visit two. Once the first pair was dispensed, the practitioner informed Chadwick Optical and the second pair was then mailed to the practitioner in time for collection by the patient at visit three. At visit three, the first pair was retained by the practitioner before the second pair was fitted. Thus the patient never had access to both pairs of glasses at the same time.
Training in how to use the prism glasses was conducted by the practitioner at visit two. As the first pair was a sham for half of the participants, training in how to use the glasses (Bowers et al., 2008) was conducted using real upper and lower horizontal peripheral prism segments mounted on a clip placed over the participant's habitual spectacles. Participants were taught to view through the central prism-free area of the spectacle lens at all times and to turn the head and eyes to fixate objects of interest that were initially detected from the prism image in peripheral vision. A simple "reach and touch" training exercise was used to familiarize participants with the relationship between the apparent and real positions of objects detected from the prism image; this exercise was also encouraged for home-training. Participants were given verbal and written instructions about how to use the prism glasses and were encouraged to wear them as much as possible each day. They were advised not to use the peripheral prism glasses for driving or prolonged reading.
After wearing the first pair of prism glasses for four weeks, the participant returned for the third visit (end of first period of crossover). After the practitioner retained the first pair of glasses, the data collector asked the question "If the study were to end today, would you want to continue with these prism glasses (i.e. the prism glasses worn in the first period)?", and also administered the mobility questionnaire for the first pair. The practitioner then fitted the second pair of glasses.
Four weeks later at the fourth visit (end of second period of crossover), the practitioner retained the second pair, the data collector then determined whether the participant would want to continue with the second pair and administered the mobility questionnaire for the second pair followed by the comparison questionnaire. After the questionnaires, the practitioner "debriefed" the participant and explained that one pair of glasses was a sham. A clinical decision whether or not to continue prism wear was then made. The criteria to continue wear were: the real prism glasses were helpful for mobility, the participant wanted to continue wear and the practitioner deemed that it was clinically appropriate. Participants were not allowed to keep sham prism glasses, even if they indicated a preference for the sham glasses.
For participants who continued to wear prism glasses, a telephone follow-up interview was conducted approximately 6 months after their final in-office visit (median 6.0 months, interquartile range 5.8 to 6.9). In our first multicenter study, the long-term follow up was at 12 months; however the majority of participants who discontinued wearing prism glasses after the clinical decision to continue did so within 3 months. Hence we selected 6 rather than 12 months for the long-term follow up for this study. Reported difficulties for real and sham prism glasses For participants who continued prism wear, the proportion reporting at least one difficulty with the prisms was similar for real and sham prism glasses (44% and 40%, respectively; eFigure). However, for participants who discontinued prism wear, the proportion reporting at least one difficulty was significantly higher for the real prism glasses (80% and 51%, respectively; p = 0.013; eFigure). In particular, they reported more difficulties with interpreting the prism image and interference in central vision (eFigure). Similarly, a higher proportion of those who discontinued than continued reported at least one difficulty with real prism glasses (eFigure -compare solid gray and black columns). By comparison, for sham prism glasses, there were no such differences between those who discontinued and continued (eFigure -compare hatched columns). Those who discontinued were more likely to report difficulties with real than sham prism glasses (compare black solid and black hatched columns) and were more likely to report difficulties with real prism glasses than those who continued (compare black solid and gray solid columns) 
Rasch Analysis of Mobility Questionnaire

